EPLAS.E — Egeplast Ege Plastik Ticaret ve Sanayi AS Balance Sheet
0.000.00%
- TRY1.34bn
- TRY1.54bn
- TRY1.55bn
- 19
- 71
- 39
- 34
Annual balance sheet for Egeplast Ege Plastik Ticaret ve Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 77.9 | 28.6 | 170 | 15.7 | 13.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 46.7 | 56.9 | 281 | 413 | 277 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 207 | 197 | 724 | 767 | 500 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.54 | 153 | 1,443 | 2,585 | 2,868 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 278 | 435 | 2,547 | 3,818 | 3,823 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 96.4 | 300 | 598 | 609 | 689 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 137 | 337 | 849 | 972 | 1,055 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 141 | 98 | 1,699 | 2,846 | 2,768 |
| Total Liabilities & Shareholders' Equity | 278 | 435 | 2,547 | 3,818 | 3,823 |
| Total Common Shares Outstanding |